Back
PT Bank Central Asia Tbk Vs. Astrana Health Industry Stock Comparison
Buy
62
PBCRF
PT Bank Central Asia Tbk
Last Price:
0.68
Seasonality Move:
10.91%
Sell
11
ASTH
Astrana Health
Last Price:
41.9300
Seasonality Move:
25.02%
Buy
62
PT Bank Central Asia Tbk (PBCRF)
is a Buy
Is PT Bank Central Asia Tbk a Buy, Sell or Hold?
- The current PT Bank Central Asia Tbk [PBCRF] share price is $0.67. The Score for PBCRF is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
- PBCRF is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
11
Astrana Health (ASTH)
is a Sell
Is Astrana Health a Buy, Sell or Hold?
- The current Astrana Health [ASTH] share price is $42.9300. The Score for ASTH is 11, which is 78% below its historic median score of 50, and infers higher risk than normal.
- ASTH is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
PBCRF Stock Price Chart
What is PT Bank Central Asia Tbk's stock price today?
-
The PT Bank Central Asia Tbk share price today is $0.67
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PBCRF is experiencing slight buying pressure.
ASTH Stock Price Chart
What is Astrana Health's stock price today?
-
The Astrana Health share price today is $42.9300
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ASTH is experiencing selling pressure, which indicates risk of future bearish movement.
PBCRF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.01 | Sell |
Relative Strength Index (14 RSI): | 49.47 | Sell |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.65 - 0.71) | Sell |
Bollinger Bands (100): | (0.6 - 0.7) | Buy |
ASTH Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.01 | Sell |
Relative Strength Index (14 RSI): | 27.01 | Sell |
Chaikin Money Flow: | -465704 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (51.464 - 60.504) | Sell |
Bollinger Bands (100): | (44.6431 - 56.9831) | Sell |
PBCRF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.67 | Buy |
20-day SMA: | 0.68 | Sell |
50-day SMA: | 0.68 | Sell |
200-day SMA: | 0.63 | Buy |
8-day EMA: | 0.66 | Buy |
20-day EMA: | 0.67 | Buy |
50-day EMA: | 0.67 | Sell |
200-day EMA: | 0.63 | Buy |
ASTH Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 52.51 | Sell |
20-day SMA: | 55.48 | Sell |
50-day SMA: | 55.12 | Sell |
200-day SMA: | 45.28 | Sell |
8-day EMA: | 50.74 | Sell |
20-day EMA: | 53.85 | Sell |
50-day EMA: | 53.99 | Sell |
200-day EMA: | 46.89 | Sell |
PT Bank Central Asia Tbk Earnings Growth & PBCRF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Astrana Health Earnings Growth & ASTH Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.76 per share, and a decrease next year of $0.13 per share.
PT Bank Central Asia Tbk Technical Analysis
Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Astrana Health Technical Analysis
Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |